antimitotic cancer therapy (Anticancer Biosciences)

N/A

Report date: 2025/03/18 18:01:54
NME

Base Information

Drug Nameantimitotic cancer therapy (Anticancer Biosciences)
Drug Alias NameMYC oncoprotein inhibitor (Anticancer Biosciences/MBICR)acetylcorynolinecorynoline and acetylcorynoline (Anticancer Biosciences/MBICR)corynolinebenzophenanthridine alkaloids (Anticancer Biosciences/MBICR)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnticancer Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnticancer Bioscience LtdJ Michael Bishop Institute of Cancer Research
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A